Literature DB >> 19568783

Regulation of the E3 ubiquitin ligase activity of MDM2 by an N-terminal pseudo-substrate motif.

Erin G Worrall1, Bartosz Wawrzynow, Liam Worrall, Malcolm Walkinshaw, Kathryn L Ball, Ted R Hupp.   

Abstract

The tumor suppressor p53 has evolved a MDM2-dependent feedback loop that promotes p53 protein degradation through the ubiquitin-proteasome system. MDM2 is an E3-RING containing ubiquitin ligase that catalyzes p53 ubiquitination by a dual-site mechanism requiring ligand occupation of its N-terminal hydrophobic pocket, which then stabilizes MDM2 binding to the ubiquitination signal in the DNA-binding domain of p53. A unique pseudo-substrate motif or "lid" in MDM2 is adjacent to its N-terminal hydrophobic pocket, and we have evaluated the effects of the flexible lid on the dual-site ubiquitination reaction mechanism catalyzed by MDM2. Deletion of this pseudo-substrate motif promotes MDM2 protein thermoinstability, indicating that the site can function as a positive regulatory element. Phospho-mimetic mutation in the pseudo-substrate motif at codon 17 (MDM2(S17D)) stabilizes the binding of MDM2 towards two distinct peptide docking sites within the p53 tetramer and enhances p53 ubiquitination. Molecular modeling orientates the phospho-mimetic pseudo-substrate motif in equilibrium over a charged surface patch on the MDM2 at Arg(97)/Lys(98), and mutation of these residues to the MDM4 equivalent reverses the activating effect of the phospho-mimetic mutation on MDM2 function. These data highlight the ability of the pseudo-substrate motif to regulate the allosteric interaction between the N-terminal hydrophobic pocket of MDM2 and its central acidic domain, which stimulates the E3 ubiquitin ligase function of MDM2. This model of MDM2 regulation implicates an as yet undefined lid-kinase as a component of pro-oncogenic pathways that stimulate the E3 ubiquitin ligase function of MDM2 in cells.

Entities:  

Year:  2009        PMID: 19568783      PMCID: PMC2725272          DOI: 10.1007/s12154-009-0019-5

Source DB:  PubMed          Journal:  J Chem Biol        ISSN: 1864-6158


  56 in total

1.  Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo.

Authors:  D Xirodimas; M K Saville; C Edling; D P Lane; S Laín
Journal:  Oncogene       Date:  2001-08-16       Impact factor: 9.867

2.  Electrostatics of nanosystems: application to microtubules and the ribosome.

Authors:  N A Baker; D Sept; S Joseph; M J Holst; J A McCammon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

3.  Expansion of protein interaction maps by phage peptide display using MDM2 as a prototypical conformationally flexible target protein.

Authors:  Lindsay Burch; Harumi Shimizu; Amanda Smith; Cam Patterson; Ted R Hupp
Journal:  J Mol Biol       Date:  2004-03-12       Impact factor: 5.469

4.  A function for the RING finger domain in the allosteric control of MDM2 conformation and activity.

Authors:  Bartosz Wawrzynow; Susanne Pettersson; Alicja Zylicz; Janice Bramham; Erin Worrall; Ted R Hupp; Kathryn L Ball
Journal:  J Biol Chem       Date:  2009-02-02       Impact factor: 5.157

5.  Metal and RNA binding properties of the hdm2 RING finger domain.

Authors:  Z Lai; D A Freedman; A J Levine; G L McLendon
Journal:  Biochemistry       Date:  1998-12-01       Impact factor: 3.162

6.  A chromatin-associated and transcriptionally inactive p53-Mdm2 complex occurs in mdm2 SNP309 homozygous cells.

Authors:  Nicoleta C Arva; Tamara R Gopen; Kathryn E Talbott; Latoya E Campbell; Agustin Chicas; David E White; Gareth L Bond; Arnold J Levine; Jill Bargonetti
Journal:  J Biol Chem       Date:  2005-05-20       Impact factor: 5.157

7.  Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26.

Authors:  Yaara Ofir-Rosenfeld; Kristy Boggs; Dan Michael; Michael B Kastan; Moshe Oren
Journal:  Mol Cell       Date:  2008-10-24       Impact factor: 17.970

8.  Role of Mdm2 acid domain interactions in recognition and ubiquitination of the transcription factor IRF-2.

Authors:  Susanne Pettersson; Michael Kelleher; Emmanuelle Pion; Maura Wallace; Kathryn L Ball
Journal:  Biochem J       Date:  2009-03-15       Impact factor: 3.857

9.  ATP stimulates MDM2-mediated inhibition of the DNA-binding function of E2F1.

Authors:  Craig Stevens; Susanne Pettersson; Bartosz Wawrzynow; Maura Wallace; Kathryn Ball; Alicja Zylicz; Ted R Hupp
Journal:  FEBS J       Date:  2008-08-27       Impact factor: 5.542

10.  Intrasteric control of AMPK via the gamma1 subunit AMP allosteric regulatory site.

Authors:  Julian Adams; Zhi-Ping Chen; Bryce J W Van Denderen; Craig J Morton; Michael W Parker; Lee A Witters; David Stapleton; Bruce E Kemp
Journal:  Protein Sci       Date:  2004-01       Impact factor: 6.725

View more
  19 in total

1.  CK1alpha plays a central role in mediating MDM2 control of p53 and E2F-1 protein stability.

Authors:  Anne-Sophie Huart; Nicola J MacLaine; David W Meek; Ted R Hupp
Journal:  J Biol Chem       Date:  2009-09-15       Impact factor: 5.157

2.  Interrogation of MDM2 phosphorylation in p53 activation using native chemical ligation: the functional role of Ser17 phosphorylation in MDM2 reexamined.

Authors:  Changyou Zhan; Kristen Varney; Weirong Yuan; Le Zhao; Wuyuan Lu
Journal:  J Am Chem Soc       Date:  2012-04-04       Impact factor: 15.419

3.  Concepts in MDM2 Signaling: Allosteric Regulation and Feedback Loops.

Authors:  Anand Ponnuswamy; Ted Hupp; Robin Fåhraeus
Journal:  Genes Cancer       Date:  2012-03

4.  Simulation of MDM2 N-terminal domain conformational lability in the presence of imidazoline based inhibitors of MDM2-p53 protein-protein interaction.

Authors:  Maxim Gureev; Daria Novikova; Tatyana Grigoreva; Svetlana Vorona; Alexander Garabadzhiu; Vyacheslav Tribulovich
Journal:  J Comput Aided Mol Des       Date:  2019-11-28       Impact factor: 3.686

5.  p53 promotes its own polyubiquitination by enhancing the HDM2 and HDMX interaction.

Authors:  Ixaura Medina-Medina; Mayra Martínez-Sánchez; Jesús Hernández-Monge; Robin Fahraeus; Petr Muller; Vanesa Olivares-Illana
Journal:  Protein Sci       Date:  2018-03-25       Impact factor: 6.725

6.  Cadmium induced p53-dependent activation of stress signaling, accumulation of ubiquitinated proteins, and apoptosis in mouse embryonic fibroblast cells.

Authors:  Xiaozhong Yu; Jaspreet S Sidhu; Sungwoo Hong; Joshua F Robinson; Rafael A Ponce; Elaine M Faustman
Journal:  Toxicol Sci       Date:  2011-01-20       Impact factor: 4.849

7.  A novel p53 phosphorylation site within the MDM2 ubiquitination signal: II. a model in which phosphorylation at SER269 induces a mutant conformation to p53.

Authors:  Jennifer A Fraser; Arumugam Madhumalar; Elizabeth Blackburn; Janice Bramham; Malcolm D Walkinshaw; Chandra Verma; Ted R Hupp
Journal:  J Biol Chem       Date:  2010-09-16       Impact factor: 5.157

Review 8.  MDM4 alternative splicing and implication in MDM4 targeted cancer therapies.

Authors:  Jin Wu; Guanting Lu; Xinjiang Wang
Journal:  Am J Cancer Res       Date:  2021-12-15       Impact factor: 6.166

Review 9.  MDMX (MDM4), a Promising Target for p53 Reactivation Therapy and Beyond.

Authors:  Jean-Christophe Marine; Aart G Jochemsen
Journal:  Cold Spring Harb Perspect Med       Date:  2016-07-01       Impact factor: 6.915

10.  Modulation of p53 binding to MDM2: computational studies reveal important roles of Tyr100.

Authors:  Shubhra Ghosh Dastidar; David P Lane; Chandra S Verma
Journal:  BMC Bioinformatics       Date:  2009-12-03       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.